Reference number : 276-2021-2022-Q2-00092, amendment number : , agreement type : C, recipient legal name : Precision BioLogic Incorporated|Precision BioLogic Incorporated, recipient country : CA, recipient province : NS, recipient city : Dartmouth|Dartmouth, recipient postal code : B3B 0A9, program name english : REGI - Business Scale-up and Productivity, program name french : CERI - Expansion et productivité des entreprises, program purpose english : nan, program purpose french : nan, agreement title english : 218650, agreement title french : 218650, agreement number : 218650, agreement value : 100000.0, agreement start date : 2021-07-29, agreement end date : 2022-06-30, description english : Engage expertise for FDA approval to commercialize new products, description french : Embaucher experts pour l’approbation de la mise en marché de nouveaux produits par la FDA, expected results english : nan, expected results french : nan, additional information english : The assistance type is Unconditionally Repayable Contribution., additional information french : Le type d'aide est contribution à remboursement inconditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique